Skip to Main Content

Paper Details

A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy.
Clin Cancer Res
11
2023
Author NameAffiliation
Toshinori HinoueVan Andel Institute
David I QuinnUniversity of Southern California Norris Comprehensive Cancer Center, Keck School of Medicine of USC
Jean-Pierre J IssaThe Coriell Institute for Medical Research
Stephen B BaylinSidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Stephen B BaylinSidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Hui ShenVan Andel Institute
Hui ShenVan Andel Institute
  • 1 - 7

Datasets

Release 1.2